Corporate presentation

DBV, a revolution in immunotherapy

News

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Events

Documentation

20F- Form 2016

Investor Relations

Phone : +33 1 55 42 78 78
Fax : +33 1 43 26 10 83